14/07/2025
📢 A new prospective study published in Scientific Reports confirms it: patients prefer for !
🔬 by Elesta was the system used in this study of 204 patients conducted by Prof. Marcin Barczyński.
Here are the highlights:
✅ 80% of patients chose laser ablation (LA)
📊 Technical success: 74.2%
📈 Clinical success: 90.2%
⚠️ Complication rate: only 1.8% (vs. 11.8% TOETVA, 8.7% surgery)
🌟 This confirms LA with EchoLaser as a safe and effective minimally invasive alternative to surgery.
👏 Thank you to Prof. Barczyński for the great work and to our partner MEDEN for the collaboration in Poland.
🔗 Full article:
A changing landscape of patients’ preferences for treatment of solitary and benign thyroid nodules (SBTN) form conventional surgery to other minimally invasive treatments (MITs) has been witnessed. The aim of this study was to evaluate indications, patients’ preferences and outcomes of conventio...
